Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NORVIUM BIOSCIENCE

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 27
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

DR REDDYS LABS LTD

  • FDA Approval
  • Nov. 22, 2024, 15:16 UTC
  • 36
  • 0 comments

FDA approve RIVAROXABAN

Comment Full text

EMCURE PHARMS LTD

  • FDA Approval
  • Nov. 22, 2024, 15:16 UTC
  • 34
  • 0 comments

FDA approve DOLUTEGRAVIR

Comment Full text

ZYLA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 24
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

BOEHRINGER INGELHEIM

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 20
  • 0 comments

FDA approve MELOXICAM

Comment Full text

HORIZON

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 26
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

SCILEX PHARMS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 21
  • 0 comments

FDA approve CELECOXIB

Comment Full text

AVONDALE PHARMS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 26
  • 0 comments

FDA approve MELOXICAM

Comment Full text

ASSERTIO

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 24
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 22
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text
  • Previous
  • 211
  • 212
  • 213
  • 214
  • 215
  • Next

Search

News categories

  • Technical Exchange News(9903)
  • Event(410)
  • SEC News(167584)
  • FDA Approval(9349)
  • Company Report(721)
  • Business News(111432)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin